First Time Loading...

Personalis Inc
NASDAQ:PSNL

Watchlist Manager
Personalis Inc Logo
Personalis Inc
NASDAQ:PSNL
Watchlist
Price: 1.25 USD -3.85% Market Closed
Updated: Apr 27, 2024

Intrinsic Value

PSNL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. [ Read More ]

The intrinsic value of one PSNL stock under the Base Case scenario is 5.36 USD. Compared to the current market price of 1.25 USD, Personalis Inc is Undervalued by 77%.

Key Points:
PSNL Intrinsic Value
Base Case
5.36 USD
Undervaluation 77%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Personalis Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PSNL stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Personalis Inc

Provide an overview of the primary business activities
of Personalis Inc.

What unique competitive advantages
does Personalis Inc hold over its rivals?

What risks and challenges
does Personalis Inc face in the near future?

Has there been any significant insider trading activity
in Personalis Inc recently?

Summarize the latest earnings call
of Personalis Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Personalis Inc.

Provide P/S
for Personalis Inc.

Provide P/E
for Personalis Inc.

Provide P/OCF
for Personalis Inc.

Provide P/FCFE
for Personalis Inc.

Provide P/B
for Personalis Inc.

Provide EV/S
for Personalis Inc.

Provide EV/GP
for Personalis Inc.

Provide EV/EBITDA
for Personalis Inc.

Provide EV/EBIT
for Personalis Inc.

Provide EV/OCF
for Personalis Inc.

Provide EV/FCFF
for Personalis Inc.

Provide EV/IC
for Personalis Inc.

Show me price targets
for Personalis Inc made by professional analysts.

What are the Revenue projections
for Personalis Inc?

How accurate were the past Revenue estimates
for Personalis Inc?

What are the Net Income projections
for Personalis Inc?

How accurate were the past Net Income estimates
for Personalis Inc?

What are the EPS projections
for Personalis Inc?

How accurate were the past EPS estimates
for Personalis Inc?

What are the EBIT projections
for Personalis Inc?

How accurate were the past EBIT estimates
for Personalis Inc?

Compare the revenue forecasts
for Personalis Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Personalis Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Personalis Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Personalis Inc compared to its peers.

Compare the P/E ratios
of Personalis Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Personalis Inc with its peers.

Analyze the financial leverage
of Personalis Inc compared to its main competitors.

Show all profitability ratios
for Personalis Inc.

Provide ROE
for Personalis Inc.

Provide ROA
for Personalis Inc.

Provide ROIC
for Personalis Inc.

Provide ROCE
for Personalis Inc.

Provide Gross Margin
for Personalis Inc.

Provide Operating Margin
for Personalis Inc.

Provide Net Margin
for Personalis Inc.

Provide FCF Margin
for Personalis Inc.

Show all solvency ratios
for Personalis Inc.

Provide D/E Ratio
for Personalis Inc.

Provide D/A Ratio
for Personalis Inc.

Provide Interest Coverage Ratio
for Personalis Inc.

Provide Altman Z-Score Ratio
for Personalis Inc.

Provide Quick Ratio
for Personalis Inc.

Provide Current Ratio
for Personalis Inc.

Provide Cash Ratio
for Personalis Inc.

What is the historical Revenue growth
over the last 5 years for Personalis Inc?

What is the historical Net Income growth
over the last 5 years for Personalis Inc?

What is the current Free Cash Flow
of Personalis Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Personalis Inc.

Financials

Balance Sheet Decomposition
Personalis Inc

Current Assets 146.7m
Cash & Short-Term Investments 114.2m
Receivables 17.7m
Other Current Assets 14.8m
Non-Current Assets 78.4m
PP&E 75.2m
Other Non-Current Assets 3.1m
Current Liabilities 47.2m
Accounts Payable 14.9m
Accrued Liabilities 21.4m
Other Current Liabilities 10.9m
Non-Current Liabilities 48.4m
Long-Term Debt 1.2m
Other Non-Current Liabilities 47.2m
Efficiency

Earnings Waterfall
Personalis Inc

Revenue
73.5m USD
Cost of Revenue
-55.3m USD
Gross Profit
18.2m USD
Operating Expenses
-114.5m USD
Operating Income
-96.3m USD
Other Expenses
-12m USD
Net Income
-108.3m USD

Free Cash Flow Analysis
Personalis Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PSNL Profitability Score
Profitability Due Diligence

Personalis Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
22/100
Profitability
Score

Personalis Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

PSNL Solvency Score
Solvency Due Diligence

Personalis Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
62/100
Solvency
Score

Personalis Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PSNL Price Targets Summary
Personalis Inc

Wall Street analysts forecast PSNL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PSNL is 4.85 USD with a low forecast of 3.54 USD and a high forecast of 7.88 USD.

Lowest
Price Target
3.54 USD
183% Upside
Average
Price Target
4.85 USD
288% Upside
Highest
Price Target
7.88 USD
530% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PSNL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PSNL Price
Personalis Inc

1M 1M
-14%
6M 6M
+29%
1Y 1Y
-45%
3Y 3Y
-95%
5Y 5Y
-96%
10Y 10Y
-96%
Annual Price Range
1.25
52w Low
0.93
52w High
2.54
Price Metrics
Average Annual Return 3.07%
Standard Deviation of Annual Returns 144.33%
Max Drawdown -98%
Shares Statistics
Market Capitalization 63.1m USD
Shares Outstanding 50 503 900
Percentage of Shares Shorted 2.96%

PSNL Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Personalis Inc Logo
Personalis Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

63.1m USD

Dividend Yield

0%

Description

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company is headquartered in Menlo Park, California and currently employs 325 full-time employees. The company went IPO on 2019-06-20. The firm is focused on the development of therapies by providing molecular data about each patient's cancer and immune response. The company provides sequencing and data analysis services to support the development of cancer therapies. Its NeXT Platform, which provides its biopharmaceutical customers with information on over 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover over 50 to 500 genes. Its NeXT Platform is designed to provide analysis of both a tumor and its immune microenvironment from a single limited tissue sample. Its platform covers the deoxyribonucleic acid sequence of all of the approximately 20,000 human genes. The company also reports on transcriptome of a tumor, which encompasses ribonucleic acid expression across human genes, allowing it to determine which of the genomic mutations might actually be driving tumor progression.

Contact

CALIFORNIA
Menlo Park
1330 Obrien Dr
+16507521300.0
http://www.personalis.com/

IPO

2019-06-20

Employees

325

Officers

President, CEO & Director
Mr. Christopher M. Hall
CFO & COO
Mr. Aaron L. Tachibana
Executive VP of R&D and Chief Medical Officer
Dr. Richard Chen M.D., M.S.
Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Michael P. Snyder Ph.D.
VP, General Counsel & Corporate Secretary
Mr. Stephen M. Moore J.D.
Vice President of Worldwide Sales
Mr. Michael J Fitzpatrick
Show More
Senior Vice President of Genomic Laboratory Operations
Dr. Christian Haudenschild Ph.D.
Senior Vice President of Business Development
Mr. Stephane Mouradian Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one PSNL stock?

The intrinsic value of one PSNL stock under the Base Case scenario is 5.36 USD.

Is PSNL stock undervalued or overvalued?

Compared to the current market price of 1.25 USD, Personalis Inc is Undervalued by 77%.